Home › Funds › Matrix Capital Management Company, LP › AURA
Matrix Capital Management Company, LP position in AURA
AURA BIOSCIENCES INC · Health Care
Matrix Capital Management Company, LP reported holding 6,922,870 shares of AURA (AURA BIOSCIENCES INC) in its Q1 2026 13F filing — a position valued at US$46.3M, representing 100.00% of its reported portfolio and ranking #1 among its reported holdings. Matrix Capital Management Company, LP has disclosed AURA holdings in 11 of the last 11 reported quarters, going back to Q3 2023.
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
How Matrix Capital Management Company, LP's AURA position evolved
Matrix Capital Management Company, LP first disclosed a stake in AURA in Q3 2023 at 5,362,870 shares (US$48.1M). The position peaked in Q3 2024 at 6,922,870 shares, worth US$61.7M. Across 11 filings, Matrix Capital Management Company, LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 9 time(s). The most recent filing (Q1 2026) shows 6,922,870 shares valued at US$46.3M. Notable position changes include a 29% increase in Q4 2023 (shares fell 11% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 5.36M | $48.10M | New |
| Q4 2023 | 6.92M | $61.34M | Add |
| Q1 2024 | 6.92M | $54.34M | Hold |
| Q2 2024 | 6.92M | $52.34M | Hold |
| Q3 2024 | 6.92M | $61.68M | Hold |
| Q4 2024 | 6.92M | $56.91M | Hold |
| Q1 2025 | 6.92M | $40.57M | Hold |
| Q2 2025 | 6.92M | $43.34M | Hold |
| Q3 2025 | 6.92M | $42.78M | Hold |
| Q4 2025 | 6.92M | $37.73M | Hold |
| Q1 2026 | 6.92M | $46.31M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About AURA and 13F data
AURA (AURA BIOSCIENCES INC) is a Health Care company. 50 other funds we track also report a position in AURA — the largest reported positions include TCG Crossover Management, LLC (US$67.7M), MONTANOVA CAPITAL, LLC (US$51.2M), Frazier Life Sciences Management, L.P. (US$50.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AURA
- TCG Crossover Management, LLC 9.53M sh · $67.69M · Q2 2026
- MONTANOVA CAPITAL, LLC 7.21M sh · $51.16M · Q2 2026
- Frazier Life Sciences Management, L.P. 7.10M sh · $50.41M · Q2 2026
- Long Focus Capital Management, LLC 5.12M sh · $36.35M · Q2 2026
- Caligan Partners LP 4.30M sh · $30.52M · Q2 2026
- FCPM III SERVICES B.V. 4.05M sh · $28.78M · Q2 2026
- Medicxi Ventures Management (Jersey) Ltd 3.04M sh · $21.58M · Q2 2026
- Nantahala Capital Management, LLC 2.95M sh · $20.95M · Q2 2026
- EcoR1 Capital, LLC 1.67M sh · $11.83M · Q2 2026
- Redmile Group, LLC 1.67M sh · $11.83M · Q2 2026
- Trails Edge Capital Partners, LP 1.44M sh · $10.25M · Q2 2026
- Foresite Capital Management VI LLC 1.33M sh · $9.47M · Q2 2026
More on Matrix Capital Management Company, LP
FAQ
How long has Matrix Capital Management Company, LP held AURA?
Matrix Capital Management Company, LP has disclosed AURA holdings in 11 of the last 11 reported quarters, going back to Q3 2023.
What is Matrix Capital Management Company, LP's current position in AURA?
As of Q1 2026, Matrix Capital Management Company, LP holds 6.92M shares of AURA (AURA BIOSCIENCES INC), valued at $46.31M, representing 100.00% of its reported portfolio and ranking #1.
Has Matrix Capital Management Company, LP been buying or selling AURA?
In the latest 13F filing (Q1 2026), Matrix Capital Management Company, LP held unchanged its position in AURA. The position peaked in Q3 2024 at 6.92M shares.
Which other funds hold AURA?
Other major institutional holders of AURA include TCG Crossover Management, LLC, MONTANOVA CAPITAL, LLC, Frazier Life Sciences Management, L.P., among 50 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.